奥氮平联合盐酸帕罗西丁治疗抑郁症的临床效果

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Olanzapine combined with Paroxetine Hydrochloride in the treatment of depression. Methods A total of 88 patients with depression admitted to Hu′nan Brain Hospital from January to October 2020 were selected as the research objects and divided into the control group and the study group according to the random number table method, with 44 cases in each group. The control group was treated with Paroxetine Hydrochloride, and the study group was treated with Olanzapine combined with Paroxetine Hydrochloride. The total effective rate, Hamilton depression scale (HAMD) and quality of life scores were compared between the two groups. Results The total effective rate of the study group was higher than that of the control group, and the difference was statistically significant (P<0.05). After intervention, the HAMD score of the study group was lower than that of the control group, and the difference was statistically significant (P<0.05). After intervention, the quality of life score of patients in the study group was higher than that in the control group,and the difference was statistically significant(P<0.05).Conclusion In the clinical treatment of patients with depression, the effect of Olanzapine combined with Paroxetine Hydrochloride treatment is better, which can effectively relieve the symptoms of patients, effectively improve the negative emotions of patients and improve their quality of life. It has certain advantages and is suitable for widespread promotion.

Key words： Olanzapine Combination therapy Paroxetine Hydrochloride Depression

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	PENG Fu-zhi
	CHEN Jin-hong▲

Cite this article:

PENG Fu-zhi,CHEN Jin-hong▲. Clinical effect of Olanzapine combined with Paroxetine Hydrochloride in the treatment of depression[J]. 中国当代医药, 2021, 28(34): 87-89.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I34/87

[1]	孙福刚，陈雪莲，周海文，等.帕罗西汀联合奥氮平对抑郁症并发睡眠障碍患者心理状态及睡眠质量的影响[J].中国药物经济学，2021，16（3）：55-57，61.
[2]	关维波.奥氮平联合盐酸帕罗西丁治疗抑郁症的疗效观察[J].中国医药指南，2020，18（3）：153-155.
[3]	翁薇洁.奥氮平片治疗难治性抑郁症对患者糖脂代谢及精神状态的影响[J].北方药学，2020，17（10）：94-95.
[4]	李东旭，宋丹丹，于人浩.重复经颅磁刺激联合盐酸帕罗西汀对卒中后抑郁症患者治疗效果观察[J].中国保健营养，2020，30（32）：33-34.
[5]	徐海燕.帕罗西汀联合奥氮平治疗抑郁症并发睡眠障碍的临床疗效观察[J].临床检验杂志（电子版），2020，9（3）：181.
[6]	程丽霞，康子才.帕罗西汀、阿立哌唑联合奥氮平应用于难治性抑郁症的效果研究[J].临床医药文献电子杂志，2020，7（47）：145.
[7]	岳亚男，郑晨星，李雷申，等.乌灵胶囊联合盐酸帕罗西丁治疗脑卒中后焦虑抑郁症106 例分析[J].北方药学，2019，16（2）：72-73.
[8]	曾惠英，宋丹杏，伍中坚.奥氮平联合盐酸帕罗西丁治疗抑郁症的疗效观察[J].现代诊断与治疗，2018，29（1）：21-23.
[9]	高崇昕，闵连秋.小剂量奥氮平治疗女性抑郁症的疗效及对患者生存质量的影响[J].中国妇幼保健，2021，36（9）：1981-1983.
[10]	黄建海，王孟璞，余萍.草酸艾司西酞普兰联合小剂量奥氮平对抑郁症患者负性情绪及神经功能的影响[J].中国基层医药，2020，27（22）：2758-2762.
[11]	岳凌峰，仲照希，马敬，等.奥氮平通过抑制NLRP3 炎症小体激活对抑郁症模型大鼠海马神经元的保护作用[J].四川大学学报（医学版），2019，50（5）：672-678.
[12]	毛新玲.奥氮平氟西汀结合阶段性认知行为干预护理措施对抑郁症患者的效果研究[J].中国药物与临床，2019，19（9）：1560-1562.
[13]	杨会增，李洁，高昕.奥氮平联合艾司西酞普兰对抑郁症患者的疗效及对神经功能与细胞因子的影响[J].中国慢性病预防与控制，2018，26（5）：375-377.
[14]	肖长久，陈海珠，程国强，等.小剂量奥氮平联合文拉法辛对重度抑郁患者急性期治疗临床效果的观察[J].国际精神病学杂志，2018，45（2）：278-281.
[15]	蔡菁，凌冬.帕罗西汀联合运动行为干预治疗抑郁症疗效及对γ-氨基丁酸的影响[J].国际检验医学杂志，2020，41（20）：2485-2488.
[16]	刘玉红.盐酸帕罗西汀结合小剂量非典型抗精神病药物在老年抑郁症患者中的应用价值[J].中国现代医生，2021，59（21）：30-33.
[17]	张程赪，张嘉骥.改良电休克联合帕罗西汀对重度抑郁症执行功能的影响[J].中国医药科学，2019，9（21）：280-283.